All News
Ozempic Blindness Lawsuit; CGM Integrates With Epic; Microdosing GLP-1 Meds
(MedPage Today) -- A Maryland man with diabetes is suing Novo Nordisk, alleging that semaglutide (Ozempic, Wegovy) made him blind due to nonarteritic anterior ischemic optic neuropathy.
Read MoreOne Dose of HPV Vaccine Noninferior to Two, Data Show
(MedPage Today) -- One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized trial showed.
Read MoreLittle Evidence That GLP-1 Agonists Affect Fertility in Men
(MedPage Today) -- LAS VEGAS -- A history of treatment with a GLP-1 receptor agonist had limited impact on sperm abnormalities in men with obesity, a retrospective cohort study suggested.
Read MoreSTAT+: Congress returns to a jam-packed agenda — here’s what we’re watching
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.
Read MoreFlu Shot Tied to Brief Menstrual Cycle Disruptions Too
(MedPage Today) -- Women's menstrual cycles temporarily became a little longer after receiving a flu shot, regardless of whether they also received a COVID vaccine at the same time, a retrospective s
Read MoreI like real maps, but mobile phones can be vital in an emergency | Brief letters
Using GPS in the wild | A toast to healthy hearts | Staffing self-checkouts | Digital assistance | Happy birthday, dear readersHaving rambled for 65 years with Ordnance Survey maps and a compass, I ag
Read MoreA closer look at the health tech executive leading Medicare
In this edition of STAT's Health Tech newsletter: A closer look at the health tech executive in charge of Medicare.
Read MoreNIH to prioritize human-based research technologies
New initiative aims to reduce use of animals in NIH-funded research.
Read MoreWhat UnitedHealth's Stock Drop Reveals About Medicare Advantage
(MedPage Today) -- UnitedHealth Group's (UHG) share price recently plummeted by more than 22%, its steepest 1-day drop in more than a quarter century.
Read More